Martin Vazquez - 01 Feb 2023 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: Chief Operating Officer
Signature: By: John L Brottem For: Martin Vazquez
Issuer symbol: OM
Transactions as of: 01 Feb 2023
Net transactions value: -$629,494
Form type: 4
Filing time: 02 Mar 2023, 17:15:02 UTC
Previous filing: 30 Jan 2023
Next filing: 16 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Options Exercise	$19,400	+5,000	+4.8%	$3.88^*	109,435	01 Feb 2023	Direct
transaction	OM	Common Stock	Sale	$139,554	-5,000	-4.6%	$27.91	104,435	01 Feb 2023	Direct	F1, F2
transaction	OM	Common Stock	Options Exercise	$25,220	+6,500	+6.2%	$3.88^*	110,935	02 Feb 2023	Direct
transaction	OM	Common Stock	Sale	$195,000	-6,500	-5.9%	$30.00	104,435	02 Feb 2023	Direct	F1
transaction	OM	Common Stock	Options Exercise	$25,220	+6,500	+6.2%	$3.88^*	110,935	02 Feb 2023	Direct
transaction	OM	Common Stock	Sale	$195,000	-6,500	-5.9%	$30.00	104,435	02 Feb 2023	Direct	F1
transaction	OM	Common Stock	Options Exercise	$25,220	+6,500	+6.2%	$3.88^*	110,935	02 Feb 2023	Direct
transaction	OM	Common Stock	Sale	$195,000	-6,500	-5.9%	$30.00	104,435	02 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-5,000	-6.8%	$0.000000	68,007	01 Feb 2023	Common Stock	5,000	$3.88	Direct	F3
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-6,500	-9.6%	$0.000000	61,507	02 Feb 2023	Common Stock	6,500	$3.88	Direct	F3
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-6,500	-11%	$0.000000	55,007	02 Feb 2023	Common Stock	6,500	$3.88	Direct	F3
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-6,500	-12%	$0.000000	48,507	02 Feb 2023	Common Stock	6,500	$3.88	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
F2	The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $27.00 - $27.99 - 3,640 shares; $28.00 - $28.99 - 1,360 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.
F3	In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.
F4	In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.